{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:35Z","timestamp":1791286955950,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.virol.2006.08.047","type":"journal-article","created":{"date-parts":[[2006,10,21]],"date-time":"2006-10-21T07:11:25Z","timestamp":1161414685000},"page":"336-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The neutralizing antibody response against West Nile virus in naturally infected horses"],"prefix":"10.1016","volume":"359","author":[{"given":"Melissa D.","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore C.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marciela M.","family":"DeGrace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri L.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Del Piero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Doms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.virol.2006.08.047_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01311358","article-title":"Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409)","volume":"105","author":"Aaskov","year":"1989","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.08.047_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/376871","article-title":"Human immunoglobulin as a treatment for West Nile virus infection","volume":"188","author":"Agrawal","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.virol.2006.08.047_bib3","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/jvi.69.9.5816-5820.1995","article-title":"Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form","volume":"69","author":"Allison","year":"1995","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.virol.2006.08.047_bib4","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virol.2006.08.047_bib5","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley","year":"2002","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2006.08.047_bib6","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JCM.42.6.2759-2765.2004","article-title":"Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection","volume":"42","author":"Beasley","year":"2004","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.virol.2006.08.047_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2006.08.047_bib8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/infdis\/130.6.634","article-title":"Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors","volume":"130","author":"Camenga","year":"1974","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2006.08.047_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virol.2005.04.031","article-title":"Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants","volume":"337","author":"Daffis","year":"2005","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2006.08.047_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2460\/javma.2005.226.240","article-title":"Immunologic responses to West Nile virus in vaccinated and clinically affected horses","volume":"226","author":"Davidson","year":"2005","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"9","key":"10.1016\/j.virol.2006.08.047_bib11","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2006.08.047_bib12","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2006.08.047_bib13","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20031223","article-title":"A critical role for induced IgM in the protection against West Nile virus infection","volume":"198","author":"Diamond","year":"2003","journal-title":"J. Exp. Med."},{"issue":"24","key":"10.1016\/j.virol.2006.08.047_bib14","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","article-title":"Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice","volume":"77","author":"Engle","year":"2003","journal-title":"J. Virol."},{"issue":"6067","key":"10.1016\/j.virol.2006.08.047_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/321244a0","article-title":"A new mechanism for the neutralization of enveloped viruses by antiviral antibody","volume":"321","author":"Gollins","year":"1986","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.virol.2006.08.047_bib16","doi-asserted-by":"crossref","first-page":"12910","DOI":"10.1128\/JVI.78.23.12910-12918.2004","article-title":"Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses","volume":"78","author":"Goncalvez","year":"2004","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.virol.2006.08.047_bib17","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1128\/JVI.78.23.12919-12928.2004","article-title":"Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein","volume":"78","author":"Goncalvez","year":"2004","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.virol.2006.08.047_bib18","doi-asserted-by":"crossref","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","article-title":"Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus","volume":"79","author":"Gould","year":"2005","journal-title":"J. Virol."},{"issue":"3\u20134","key":"10.1016\/j.virol.2006.08.047_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01309481","article-title":"Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice","volume":"137","author":"Halevy","year":"1994","journal-title":"Arch. Virol."},{"issue":"6","key":"10.1016\/j.virol.2006.08.047_bib20","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/377172","article-title":"The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis","volume":"37","author":"Haley","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2006.08.047_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1399-3062.2002.01014.x","article-title":"Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis","volume":"4","author":"Hamdan","year":"2002","journal-title":"Transplant. Infect. Dis."},{"issue":"21","key":"10.1016\/j.virol.2006.08.047_bib22","doi-asserted-by":"crossref","first-page":"13262","DOI":"10.1128\/JVI.79.21.13262-13274.2005","article-title":"N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity","volume":"79","author":"Hanna","year":"2005","journal-title":"J. Virol."},{"issue":"1\u20132","key":"10.1016\/j.virol.2006.08.047_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-0934(01)00346-9","article-title":"A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen","volume":"97","author":"Hunt","year":"2001","journal-title":"J. Virol. Methods"},{"issue":"6","key":"10.1016\/j.virol.2006.08.047_bib24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4269\/ajtmh.1989.40.676","article-title":"Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus","volume":"40","author":"Innis","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"7\u20138","key":"10.1016\/j.virol.2006.08.047_bib25","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0264-410X(01)00446-7","article-title":"Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine","volume":"20","author":"Konishi","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virol.2006.08.047_bib26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.virol.2006.08.047_bib27","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2006.08.047_bib28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00705-002-0809-3","article-title":"Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus","volume":"147","author":"Kroeger","year":"2002","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.virol.2006.08.047_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.virol.2006.08.047_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2005.02.011","article-title":"Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains","volume":"335","author":"Li","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.08.047_bib31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/jvi.63.2.564-571.1989","article-title":"Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model","volume":"63","author":"Mandl","year":"1989","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.08.047_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"issue":"Suppl. 18","key":"10.1016\/j.virol.2006.08.047_bib33","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","author":"Minke","year":"2004","journal-title":"Arch. Virol."},{"issue":"12","key":"10.1016\/j.virol.2006.08.047_bib34","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.virol.2006.08.047_bib35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/JVI.79.2.1223-1231.2005","article-title":"Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein","volume":"79","author":"Modis","year":"2005","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virol.2006.08.047_bib36","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc. Natl. Acad Sci. U.S.A."},{"issue":"5643","key":"10.1016\/j.virol.2006.08.047_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1089316","article-title":"Structure of West Nile virus","volume":"302","author":"Mukhopadhyay","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.virol.2006.08.047_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3201\/eid0704.017417","article-title":"West Nile outbreak in horses in southern France, 2000: the return after 35 years","volume":"7","author":"Murgue","year":"2001","journal-title":"Emerging Infect. Dis."},{"issue":"7059","key":"10.1016\/j.virol.2006.08.047_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.virol.2006.08.047_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.virol.2006.08.047_bib41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3201\/eid0704.017412","article-title":"Equine West Nile encephalitis, United States","volume":"7","author":"Ostlund","year":"2001","journal-title":"Emerging Infect. Dis."},{"issue":"Pt. 2","key":"10.1016\/j.virol.2006.08.047_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1099\/0022-1317-58-2-283","article-title":"Monoclonal antibodies against the flavivirus West Nile","volume":"58","author":"Peiris","year":"1982","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.08.047_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"issue":"40\u201341","key":"10.1016\/j.virol.2006.08.047_bib44","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2006.06.008","article-title":"Chimeric West Nile\/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity","volume":"24","author":"Pletnev","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.virol.2006.08.047_bib45","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2460\/javma.2003.222.1241","article-title":"West Nile virus encephalomyelitis in horses: 46 cases (2001)","volume":"222","author":"Porter","year":"2003","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"3","key":"10.1016\/j.virol.2006.08.047_bib46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1089\/vim.2005.18.558","article-title":"Neutralizing monoclonal antibodies against Russian strain of the West Nile virus","volume":"18","author":"Razumov","year":"2005","journal-title":"Viral Immunol."},{"issue":"6529","key":"10.1016\/j.virol.2006.08.047_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.virol.2006.08.047_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","article-title":"Antigenic structure of flavivirus proteins","volume":"59","author":"Roehrig","year":"2003","journal-title":"Adv. Virus Res."},{"issue":"2","key":"10.1016\/j.virol.2006.08.047_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/viro.1998.9200","article-title":"Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica","volume":"246","author":"Roehrig","year":"1998","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2006.08.047_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2460\/javma.2004.225.267","article-title":"Outcome of equids with clinical signs of West Nile virus infection and factors associated with death","volume":"225","author":"Salazar","year":"2004","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"1","key":"10.1016\/j.virol.2006.08.047_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2005.02.020","article-title":"Characterization of neutralizing antibodies to West Nile virus","volume":"336","author":"Sanchez","year":"2005","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virol.2006.08.047_bib52","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/jvi.70.7.4549-4557.1996","article-title":"Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions","volume":"70","author":"Schalich","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.08.047_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00034983.1963.11686194","article-title":"Natural and experimental infection of Egyptian equines with West Nile virus","volume":"57","author":"Schmidt","year":"1963","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"4","key":"10.1016\/j.virol.2006.08.047_bib54","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3201\/eid0704.017432","article-title":"Treatment of West Nile virus encephalitis with intravenous immunoglobulin","volume":"7","author":"Shimoni","year":"2001","journal-title":"Emerging Infect. Dis."},{"issue":"11","key":"10.1016\/j.virol.2006.08.047_bib55","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2460\/ajvr.2004.65.1459","article-title":"Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses","volume":"65","author":"Siger","year":"2004","journal-title":"Am. J. Vet. Res."},{"issue":"10","key":"10.1016\/j.virol.2006.08.047_bib56","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2460\/javma.2001.218.1576","article-title":"West Nile virus encephalomyelitis in eight horses","volume":"218","author":"Snook","year":"2001","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"12","key":"10.1016\/j.virol.2006.08.047_bib57","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerging Infect. Dis."},{"issue":"9","key":"10.1016\/j.virol.2006.08.047_bib58","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J. Immunol."},{"issue":"Pt. 4","key":"10.1016\/j.virol.2006.08.047_bib59","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1099\/0022-1317-70-4-987","article-title":"An analysis of the antibody response against West Nile virus E protein purified by SDS-PAGE indicates that this protein does not contain sequential epitopes for efficient induction of neutralizing antibodies","volume":"70","author":"Wengler","year":"1989","journal-title":"J. Gen. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206006192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206006192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:46:14Z","timestamp":1758584774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682206006192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0042682206006192"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2006.08.047","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neutralizing antibody response against West Nile virus in naturally infected horses","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2006.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}